Synergy's Incoming FDA Catalyst
December 05, 2016 at 14:53 PM EST
Timothy Chiang of BTIG remains Buy-rated on Synergy Pharmaceuticals Inc (NASDAQ: SGYP) ahead of the company's Phase 3 data for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.